Campanati Anna

60PUBLICATIONS
129CO-AUTHORS
Traditional Chinese medicine and treatmentsPredictive and prognostic markersMajor global burdens of diseaseToxicology (incl. clinical toxicology)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Mar 23, 2026
Advances in pharmacological treatment and management of hyperhidrosis.

A Rossi, H Gioacchini, A Marani

|Mar 07, 2026
TROP-2 Is Not a Therapeutic Target in Melanoma: a Morphological Study.

Sonia Fantone, Daniela Marzioni, Elisa Molinelli

|Feb 16, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis).

Emanuele Trovato, Alessandra Cartocci, Francesca Gaiani

|Sep 04, 2025
Strategies for Optimal Use of Biological Therapies in Managing Psoriasis: Focus on Secukinumab.

Anna Balato, Martina Burlando, Anna Campanati

|May 13, 2025
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

Helena Gioacchini, Agnese Rossi, Maria Esposito

|Apr 16, 2025
Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.

Gianluca Avallone, Carlo Alberto Maronese, Martina Zussino

Pageof 10

Frequent Collaborators

22 joint publications

Federico Diotallevi

21 joint publications

Radi Giulia

15 joint publications

Annamaria Offidani

12 joint publications

Elisa Molinelli